Cargando…

Impact of COVID-19 on anxiety levels among patients with cancer actively treated with systemic therapy

BACKGROUND: Life-threatening diseases have a negative impact on emotional well-being and psychosocial functioning. This study aimed to assess the relationship between the level of anxiety caused by a neoplasm and the threat of coronavirus infection among patients with cancer actively treated with sy...

Descripción completa

Detalles Bibliográficos
Autores principales:	Sigorski, Dawid, Sobczuk, Paweł, Osmola, Małgorzata, Kuć, Kamil, Walerzak, Anna, Wilk, Michal, Ciszewski, Tomasz, Kopeć, Sylwia, Hryń, Karolina, Rutkowski, Piotr, Stec, Rafał, Szczylik, Cezary, Bodnar, Lubomir
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BMJ Publishing Group 2020
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7590347/ https://www.ncbi.nlm.nih.gov/pubmed/33097653 http://dx.doi.org/10.1136/esmoopen-2020-000970

Ejemplares similares

1753P Coronavirus or cancer: What are oncological patients most afraid of?
por: Sigorski, D.S., et al.
Publicado: (2020)

Incorporating Neutrophil-to-lymphocyte Ratio and Platelet-to-lymphocyte Ratio in Place of Neutrophil Count and Platelet Count Improves Prognostic Accuracy of the International Metastatic Renal Cell Carcinoma Database Consortium Model
por: Chrom, Pawel, et al.
Publicado: (2018)

Real-life data of abiraterone acetate and enzalutamide treatment in post-chemotherapy metastatic castration-resistant prostate cancer in Poland
por: Sigorski, Dawid, et al.
Publicado: (2023)

Attitudes of Patients with Cancer towards Vaccinations—Results of Online Survey with Special Focus on the Vaccination against COVID-19
por: Brodziak, Anna, et al.
Publicado: (2021)

Chromophobe renal cell cancer - review of the literature and potential methods of treating metastatic disease
por: Stec, Rafał, et al.
Publicado: (2009)

Biomarkers defining probability of receiving second-line targeted therapy in metastatic renal cell carcinoma
por: Chrom, Pawel, et al.
Publicado: (2018)

The role of Tau protein in resistance to paclitaxel
por: Smoter, Marta, et al.
Publicado: (2011)

Tau protein as a potential predictive marker in epithelial ovarian cancer patients treated with paclitaxel/platinum first-line chemotherapy
por: Smoter, Marta, et al.
Publicado: (2013)

Poly(ADP-Ribose) Polymerase Inhibitors in Prostate Cancer: Molecular Mechanisms, and Preclinical and Clinical Data
por: Sigorski, Dawid, et al.
Publicado: (2020)

Prognostic Significance of Wnt-1, β-catenin and E-cadherin Expression in Advanced Colorectal Carcinoma
por: Stanczak, Aleksandra, et al.
Publicado: (2011)

Overexpression of epidermal growth factor receptor as a prognostic factor in colorectal cancer on the basis of the Allred scoring system
por: Rokita, Marta, et al.
Publicado: (2013)

K-Ras gene mutation status as a prognostic and predictive factor in patients with colorectal cancer undergoing irinotecan- or oxaliplatin-based chemotherapy
por: Stec, Rafał, et al.
Publicado: (2012)

Renal cell carcinoma with intramyocardial metastases
por: Czarnecka, Anna M, et al.
Publicado: (2014)

Renin angiotensin system deregulation as renal cancer risk factor
por: Sobczuk, Paweł, et al.
Publicado: (2017)

Malignant tumors in patients with end stage renal failure undergoing renal replacement therapy
por: Kade, Grzegorz, et al.
Publicado: (2012)

The Use of ctDNA for BRAF Mutation Testing in Routine Clinical Practice in Patients with Advanced Melanoma
por: Sobczuk, Paweł, et al.
Publicado: (2022)

Colorectal cancer in the course of familial adenomatous polyposis syndrome (“de novo” pathogenic mutation of APC gene): case report, review of the literature and genetic commentary
por: Stec, Rafał, et al.
Publicado: (2010)

Axitinib in sequential therapy in metastatic renal cell carcinoma
por: Kuchar, Agata, et al.
Publicado: (2016)

Metastatic Tumor Burden and Loci as Predictors of First Line Sunitinib Treatment Efficacy in Patients with Renal Cell Carcinoma
por: Czarnecka, Anna M., et al.
Publicado: (2019)

Influence of Tyrosine Kinase Inhibitors on Hypertension and Nephrotoxicity in Metastatic Renal Cell Cancer Patients
por: Semeniuk-Wojtaś, Aleksandra, et al.
Publicado: (2016)

Clinical features and outcomes of germline mutation BRCA1-linked versus sporadic ovarian cancer patients
por: Synowiec, Agnieszka, et al.
Publicado: (2016)

Hypoxia-Mediated Decrease of Ovarian Cancer Cells Reaction to Treatment: Significance for Chemo- and Immunotherapies
por: Klemba, Aleksandra, et al.
Publicado: (2020)

Wnt/β-catenin pathway as a potential prognostic and predictive marker in patients with advanced ovarian cancer
por: Bodnar, Lubomir, et al.
Publicado: (2014)

Cardiac Biomarkers and Geriatric Assessment in Metastatic Castrate-Resistant Prostate Cancer During Abiraterone Acetate Therapy – A Cardio-Oncology Study
por: Wilk, Michał, et al.
Publicado: (2022)

Molecular Biology of Osteosarcoma
por: Czarnecka, Anna M., et al.
Publicado: (2020)

Genomic Analysis as the First Step toward Personalized Treatment in Renal Cell Carcinoma
por: Bielecka, Zofia Felicja, et al.
Publicado: (2014)

Hedgehog pathway in sarcoma: from preclinical mechanism to clinical application
por: Banaszek, Natalia, et al.
Publicado: (2023)

Systemic Treatment for Advanced and Metastatic Malignant Peripheral Nerve Sheath Tumors—A Sarcoma Reference Center Experience
por: Sobczuk, Paweł, et al.
Publicado: (2020)

Prognostic Significance of Survivin Expression in Patients with Ovarian Carcinoma: A Meta-Analysis
por: Gąsowska-Bajger, Beata, et al.
Publicado: (2021)

Breast cancer risk factors
por: Kamińska, Marzena, et al.
Publicado: (2015)

System for Patterning Polydopamine and VAPG Peptide on Polytetrafluoroethylene and Biodegradable Polyesters for Patterned Growth of Smooth Muscle Cells In Vitro
por: Kopeć, Kamil, et al.
Publicado: (2023)

Value choices in European COVID-19 vaccination schedules: how vaccination prioritization differs from other forms of priority setting
por: Wiśniowska, Karolina, et al.
Publicado: (2022)

Anticancer, antioxidant, and antibacterial activities of low molecular weight bioactive subfractions isolated from cultures of wood degrading fungus Cerrena unicolor
por: Matuszewska, Anna, et al.
Publicado: (2018)

Sorafenib in progressive castrate-resistant prostate cancer. Can we talk about a new therapeutic option?
por: Zaborowska, Magdalena, et al.
Publicado: (2012)

Seeking new prognostic and predictive factors in patients with metastatic renal cell carcinoma – apoptosis-regulating factors
por: Młot, Beata, et al.
Publicado: (2012)

Seeking new prognostic and predictive factors in patients with metastatic renal cell carcinoma – hypoxia-induced factors
por: Młot, Beata, et al.
Publicado: (2012)

The Nephrotoxicity of Drugs Used in Causal Oncological Therapies
por: Hałka, Janusz, et al.
Publicado: (2022)

Application of FTIR-ATR Spectroscopy to Determine the Extent of Lipid Peroxidation in Plasma during Haemodialysis
por: Oleszko, Adam, et al.
Publicado: (2015)

Immune consequences of anti-angiogenic therapyin renal cell carcinoma
por: Brodaczewska, Klaudia K., et al.
Publicado: (2018)

Caspase-14—From Biomolecular Basics to Clinical Approach. A Review of Available Data
por: Markiewicz, Agnieszka, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_q05r5d5aot1eu34d1q6c0kicef